• Skip to content
  • Skip to primary sidebar
Veloxis
  • Home
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents
  • Products
    • Our Technology
    • ENVARSUS XR
  • News & Releases
  • Careers
  • Contact Us
Home / Company / Governance Documents

Governance Documents

Governance Statements

Statutory Corporate Governance Report for 2018, cf. art. 107b of the Danish Financial Statements Act
Statutory Corporate Governance Report for 2017, cf. art. 107b of the Danish Financial Statements Act
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2016)
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2015)
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2014)
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2013)
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2012)
Statutory statement of corporate governance, cf. section 107b of the Danish Financial Statements Act (2011)
Veloxis Corporate Governance 2011 – English

 

US Compliance Statements

Code of Business Conduct

US Compliance Statements

To request a summary of the Veloxis Comprehensive Compliance Program, please call +1 919 591 3090.

 

Documents

Articles of Association
Remuneration Committee Charter
Audit Committee Charter
Rules of Procedure for the Board of Directors
Efforts by Veloxis to Obtain Final Approval for Envarsus® XR from the Food and …
IR Policy
Remuneration Policy

Primary Sidebar

Company

  • Overview
  • Management Team
  • Board of Directors

News & Releases

  • Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program
    Jun 18, 2020
  • Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
    Feb 17, 2020
  • Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S’ Request for Delisting of its Shares from Nasdaq Copenhagen A/S
    Jan 29, 2020

Read More

©2018 All rights reserved. Veloxis Pharmaceuticals, Inc. ENV-18-061.1 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

©2018 All rights reserved. Veloxis Pharmaceuticals, Inc. ENV-18-065.1 06/18

info@veloxis.com | 1-844-VELOXIS (835-6947), Monday-Friday, 9AM-7PM ET

Sitemap | Contact | Privacy Policy | Disclaimer

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.